title: Lithium-induced neuroprotection is associated with epigenetic modification of specific BDNF gene promoter and altered expression of apoptotic-regulatory proteins.
abstract: Bipolar disorder (BD), one of the most debilitating mental disorders, is associated with increased morbidity and mortality. Lithium is the first line of treatment option for BD and is often used for maintenance therapy. Recently, the neuroprotective action of lithium has gained tremendous attention, given that BD is associated with structural and functional abnormalities of the brain. However, the precise molecular mechanism by which lithium exerts its neuroprotective action is not clearly understood. In hippocampal neurons, the effects of lithium (1 and 2 mM) on neuronal viability against glutamate-induced cytotoxicity, dendritic length and number, and expression and methylation of BDNF promoter exons and expression of apoptotic regulatory genes were studied. In rat hippocampal neurons, lithium not only increased dendritic length and number, but also neuronal viability against glutamate-induced cytotoxicity. While lithium increased the expression of BDNF as well as genes associated with neuroprotection such as Bcl2 and Bcl-XL, it decreased the expression of pro-apoptotic genes Bax, Bad, and caspases 3. Interestingly, lithium activated transcription of specific exon IV to induce BDNF gene expression. This was accompanied by hypomethylation of BDNF exon IV promoter. This study delineates mechanisms by which lithium mediates its effects in protecting neurons.
authors: Department of Psychiatry, University of Illinois at Chicago Chicago, IL, USA.
authors: Tushar
authors: T
authors: Dwivedi
authors: Department of Psychiatry, University of Illinois at Chicago Chicago, IL, USA.
authors: Hui
authors: H
authors: Zhang
keywords: BDNF; apoptotic regulatory genes; bipolar; hippocampal culture; lithium; methylation
references: J Psychiatr Res. 2010 Jun;44(8):506-10
references: 19954800
references: Annu Rev Neurosci. 2001;24:677-736
references: 11520916
references: Biol Psychiatry. 2000 Jul 1;48(1):1-8
references: 10913502
references: Biol Psychiatry. 2007 Dec 1;62(11):1310-6
references: 17574216
references: C R Biol. 2005 Jul;328(7):616-31
references: 15992745
references: Mol Cell Biol. 1996 Oct;16(10):5546-56
references: 8816467
references: Neuropsychopharmacology. 2012 Jun;37(7):1647-55
references: 22353757
references: Brain Res. 2007 Jan 5;1127(1):108-18
references: 17113057
references: Eur J Hum Genet. 2015 Sep;23(9):1200-6
references: 25406999
references: Neurosci Biobehav Rev. 2014 May;42:132-47
references: 24603026
references: Am J Med Genet B Neuropsychiatr Genet. 2014 Jun;165B(4):365-72
references: 24804643
references: Arch Gen Psychiatry. 2000 Oct;57(10):925-35
references: 11015810
references: Psychiatry Res. 2006 Jun 30;147(1):1-25
references: 16806850
references: Curr Opin Neurobiol. 2001 Apr;11(2):240-9
references: 11301246
references: Biol Mood Anxiety Disord. 2012 Sep 12;2:15
references: 22967286
references: Psychiatr Clin North Am. 2005 Jun;28(2):443-67
references: 15826742
references: Pflugers Arch. 2007 Oct;455(1):19-30
references: 17558519
references: Mol Psychiatry. 2009 Apr;14 (4):448-61
references: 18227838
references: Cell Transplant. 2009;18(9):951-75
references: 19523343
references: Psychiatr Genet. 2012 Oct;22(5):253-5
references: 22517381
references: Br J Psychiatry. 2004 Jun;184:496-502
references: 15172943
references: PLoS Med. 2009 Aug;6(8):e1000123
references: 19668361
references: Expert Rev Neurother. 2008 Jul;8(7):1101-13
references: 18590480
references: Bipolar Disord. 2015 May;17(3):248-56
references: 25257942
references: Genes Brain Behav. 2010 Jun 1;9(4):411-8
references: 20132317
references: Proc Natl Acad Sci U S A. 2003 May 27;100(11):6370-5
references: 12750461
references: Genes Brain Behav. 2010 Jul;9(5):503-11
references: 20214684
references: Bipolar Disord. 2008 Feb;10(1):95-100
references: 18199246
references: J Affect Disord. 2014 Sep;166:285-91
references: 25012443
references: Semin Clin Neuropsychiatry. 2002 Oct;7(4):269-80
references: 12382209
references: Eur Neuropsychopharmacol. 2006 Jan;16(1):71-7
references: 16023835
references: Neurosci Lett. 2003 Jul 10;345(1):53-6
references: 12809987
references: Lancet. 2000 Oct 7;356(9237):1241-2
references: 11072948
references: Curr Pharm Des. 2012;18(12):1605-8
references: 22280433
references: J Am Acad Child Adolesc Psychiatry. 2005 Jun;44(6):565-73
references: 15908839
references: Curr Opin Psychiatry. 2006 May;19(3):313-23
references: 16612219
references: Eur J Biochem. 1998 Jun 15;254(3):439-59
references: 9688254
references: Neurosci Lett. 2006 May 8;398(3):215-9
references: 16480819
references: J Neurosci Res. 2007 Feb 15;85(3):525-35
references: 17149751
references: J Neurosci. 2008 Oct 15;28(42):10576-86
references: 18923034
references: World J Biol Psychiatry. 2011 Aug;12(5):340-8
references: 21361856
references: Biol Psychiatry. 2006 Jun 1;59(11):1006-20
references: 16487491
references: Int J Neuropsychopharmacol. 2011 Sep;14(8):1075-89
references: 21205433
references: Nature. 2000 Oct 12;407(6805):802-9
references: 11048732
references: Expert Rev Neurother. 2014 Jan;14(1):51-65
references: 24308275
references: J Neurosci. 2005 May 4;25(18):4493-502
references: 15872096
references: Neuropsychopharmacology. 2013 Feb;38(3):468-75
references: 23072837